A detailed history of Jpmorgan Chase & CO transactions in Schrodinger, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 118,299 shares of SDGR stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,299
Previous 206,497 42.71%
Holding current value
$2.16 Million
Previous $5.58 Million 58.98%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$18.65 - $28.5 $1.64 Million - $2.51 Million
-88,198 Reduced 42.71%
118,299 $2.29 Million
Q1 2024

May 10, 2024

SELL
$24.74 - $35.13 $707,143 - $1 Million
-28,583 Reduced 12.16%
206,497 $5.58 Million
Q4 2023

Feb 12, 2024

SELL
$21.62 - $37.21 $638,222 - $1.1 Million
-29,520 Reduced 11.16%
235,080 $8.42 Million
Q3 2023

Nov 14, 2023

BUY
$27.34 - $55.37 $70,400 - $142,577
2,575 Added 0.98%
264,600 $7.48 Million
Q2 2023

Aug 11, 2023

SELL
$26.1 - $49.92 $1.79 Million - $3.43 Million
-68,698 Reduced 20.77%
262,025 $13.1 Million
Q1 2023

May 18, 2023

BUY
$18.09 - $27.61 $1.22 Million - $1.86 Million
67,488 Added 25.64%
330,723 $8.71 Million
Q1 2023

May 11, 2023

SELL
$18.09 - $27.61 $2.64 Million - $4.03 Million
-145,957 Reduced 35.67%
263,235 $6.93 Million
Q4 2022

Feb 13, 2023

SELL
$16.24 - $26.38 $239,637 - $389,263
-14,756 Reduced 3.48%
409,192 $7.65 Million
Q3 2022

Nov 14, 2022

SELL
$23.95 - $34.71 $266,228 - $385,836
-11,116 Reduced 2.56%
423,948 $10.6 Million
Q2 2022

Aug 11, 2022

BUY
$21.39 - $35.9 $2.85 Million - $4.78 Million
133,277 Added 44.16%
435,064 $11.5 Million
Q1 2022

May 11, 2022

SELL
$24.84 - $36.12 $98,316 - $142,962
-3,958 Reduced 1.29%
301,787 $10.3 Million
Q4 2021

Feb 10, 2022

BUY
$33.38 - $59.25 $25,201 - $44,733
755 Added 0.25%
305,745 $10.6 Million
Q3 2021

Nov 12, 2021

BUY
$53.75 - $76.55 $16.4 Million - $23.3 Million
304,990 New
304,990 $16.7 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.13B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.